West Pharmaceutical Servs: Q4 Earnings Insights

West Pharmaceutical Servs WST reported its Q4 earnings results on Thursday, February 17, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

West Pharmaceutical Servs beat estimated earnings by 6.81%, reporting an EPS of $2.04 versus an estimate of $1.91.

Revenue was up $150.60 million from the same period last year.

Last quarter the company beat on EPS by $0.26, which was followed by a 2.08% increase in the share price the next day.

Here's a look at West Pharmaceutical Servs's past performance:

Quarter	Q3 2021	Q2 2021	Q1 2021	Q4 2020
EPS Estimate	1.80	1.74	1.43	1.12
EPS Actual	2.06	2.46	2.05	1.34
Revenue Estimate	687.09M	669.38M	611.39M	543.67M
Revenue Actual	706.50M	723.60M	670.70M	580.20M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar